PCPA in the news – PCPA invites medical oncologists and cancer nurses to participate in genomics workshop

Posted February 15, 2024

Australia’s peak body for private cancer specialists will host a workshop for all medical oncologists and
cancer nurses to gain a practical immersion into how genomic testing can better refine diagnoses, help
predict cancer behaviour and create more effective treatment plans for their patients.

Click here to read…

PCPA in the news – High demand topic for oncologists

Posted 15 February 2024

Some oncologists are still battling to get their hands on genetic testing information to diagnose and treat cancer patients – and an upcoming pharma-supported workshop hopes to fix that.

Click here to read full article.

 

PCPA in the news – PCPA Launches Practical Genomics Workshop

15 February 2024

PCPA invites medical oncologists and cancer nurses to immerse in the game-changing world of precision medicine

Melbourne.  Due to high demand, Australia’s peak body for private cancer specialists will host a unique workshop for all medical oncologists and cancer nurses, to gain a practical immersion into how genomic testing can better refine diagnoses, help predict cancer behaviour and create more effective treatment plans for their patients.

Board member of the Private Cancer Physicians of Australia (PCPA) and workshop Master of Ceremonies, Dr Cameron McLaren, says genomic testing or precision medicine, is a powerful tool that remarkably unlocks the secrets of a patient’s cancer at the genetic level.

“Genomic testing, once a futuristic view of how cancer may be treated, is now transforming cancer care by offering personalised insights for both the patient and those who care for them,” Dr McLaren says. “As importantly as finding new treatments that can help our patients, genomic testing also allows us to choose which treatments will not help, so we can avoid subjecting our patients to toxicities of ineffective treatments.”

Click here to read more

PCPA in the news – Patient groups, clinicians and industry challenge the status quo at rare diseases inquiry hearing

 

Health Industry Hub 1 February 2024

Pharma News: The Senate Community Affairs References Committee, chaired by Green’s Senator Janet Rice, held a public hearing in Sydney yesterday, spearheading an Opposition-led inquiry into equitable access to diagnosis and treatment for individuals with rare and less common cancers.

Addressing the committee, Associate Professor Christopher Steer, President of Private Cancer Physicians of Australia, emphasised “We need to end the cancer lottery where a patient with a particular diagnosis can get support for their treatment whereas another is denied … because their cancer is of the wrong type.”

Click here to read the full article.

PCPA in the news – ‘Patients should not be lost in our overly complex health system’, says Private Cancer Physicians of Australia

Health Industry Hub 20 November 2023

Click here to read the full article

Please also refer to the below link to The Hon Mark Butler MP’s media release in relation to this topic.

New era in cancer care for all Australians

PCPA in the news – New podcast urges stakeholders to speak out on access to new technologies

June 30, 2023

 

 

 

AstraZeneca has supported a new podcast that calls for accelerated access to innovative precision medicines and genomic profiling.The podcast is the third in the Private Cancer Physicians of Australia’s (PCPA’s) Cancer Patient Management series.

PCPA, Australia’s peak body for private cancer specialists, has joined other oncology and patient groups to advocate for removing the cost and regulatory barriers for patients with cancer accessing upfront molecular profiling.

Click here to read the full article.

Click here to listen to the podcast on apple podcast

Click here to listen to the podcast on spotify

PCPA in the news – New platform for oncologist MedEd

pharma in focus 19 June – 23 June 2023

 

Posted 21 June 2023

Pharma has a key role to play in helping cancer specialists meet their professional development requirements – and a new digital platform could help that partnership grow further.

The Private Cancer Physicians of Australia (PCPA) has announced the launch of a new digital platform, CPD4MedProfessional.com, which will help cancer specialists meet their updated continuing professional development (CPD) requirements.

The new online support program has been developed with the PCPA’s education partners ScienceToLife.

Currently seven pharma companies are part of the PCPA Strategic Alliance Partnership program, supporting educational activities that help medical and radiation oncologists and haematologists meet their continuing professional development (CPD) requirements.

Click here to read the full article

 

PCPA in the news – can ‘smart bombs’ replace chemo?

pharma in focus 13 June – 16 June 2023

Posted 15 June 2023

Antibody-drug conjugates (ADCs), described as “biological missiles” and “smart bombs” against cancer, could have the potential to replace chemotherapy for metastatic breast cancer.

Speaking on the Private Cancer Physicians of Australia Podcast series, University of California San Francisco Director of Breast Oncology Professor Hope Rugo said the precise and potent surface-antibody drugs were proving effective and better tolerated than existing treatments.

“This is such an exciting topic for all of us,” Rugo said. “It pervades everything we are discussing now in terms of treatment and clinical practice and research.”

She said ADCs, which contain a cancer-specific monoclonal antibody covalently attached to a cytotoxic drug through a chemical linker, were providing effective in different breast cancer subtypes.

Click here to read the full article.

Click here to listen to the podcast on apple podcast

Click here to listen to the podcast on Spotify

PCPA in the news – Unveiling the power of empathy: Gilead joins oncologists in bridging the gap

Health Industry Hub 26 May 2023

Pharma News: In an event that showcased the cutting-edge advancements in cancer treatment, the Private Cancer Physicians of Australia (PCPA) joined forces with GenesisCare, their Strategic Alliance Partner, to successfully launch the inaugural PCPA Live Multidisciplinary Teams (MDT) Masterclass. This event witnessed healthcare leaders from Gilead Australia immerse themselves in the daily life of breast cancer patients undergoing complex treatments, providing a unique opportunity to gain invaluable insights into the challenges faced by patients and their MDT teams.

Under the esteemed guidance of PCPA Board member and renowned GenesisCare Medical Oncologist, Professor Stephen Clarke, alongside esteemed colleagues Dr Katrina Moore and Dr Sally Baron-Hay, more than 15 industry leaders in cancer care came together at the North Shore Campus in Sydney. This facility, which encompasses both GenesisCare and the prestigious Royal North Shore Hospital, served as the perfect setting for the interactive Masterclass.

Click here to read the full article.

PCPA in the news – Leaders get up close in cancer care

pharma in focus 26th May 2023

Gilead leaders attended a newly launched Multidisciplinary Teams (MDT) Masterclass in cancer treatment this week hailed as an “immersive experience” to help deliver better outcomes for breast cancer patients.

The two-day interactive masterclass is an initiative of the peak body for private cancer clinicians, Private Cancer Physicians of Australia (PCPA) and its strategic alliance partner, GenesisCare.

It was held at the North Shore Campus in Sydney, which incorporates GenesisCare and Royal North Shore Hospital.

Click here to read the full article.